A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.46 USD -2.76% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Long-Term Debt
$2.5B
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Long-Term Debt
$31.6B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
9%
Bristol-Myers Squibb Co
NYSE:BMY
Long-Term Debt
$48.9B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
21%
Pfizer Inc
NYSE:PFE
Long-Term Debt
$57.5B
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
6%
Merck & Co Inc
NYSE:MRK
Long-Term Debt
$34.7B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Long-Term Debt
$23.7B
CAGR 3-Years
17%
CAGR 5-Years
12%
CAGR 10-Years
16%

See Also

What is Amneal Intermediate Inc's Long-Term Debt?
Long-Term Debt
2.5B USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Long-Term Debt amounts to 2.5B USD.

What is Amneal Intermediate Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-1%

Over the last year, the Long-Term Debt growth was -8%. The average annual Long-Term Debt growth rates for Amneal Intermediate Inc have been -4% over the past three years , -1% over the past five years .

Back to Top